ATA348378A - Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen - Google Patents

Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen

Info

Publication number
ATA348378A
ATA348378A AT348378A AT348378A ATA348378A AT A348378 A ATA348378 A AT A348378A AT 348378 A AT348378 A AT 348378A AT 348378 A AT348378 A AT 348378A AT A348378 A ATA348378 A AT A348378A
Authority
AT
Austria
Prior art keywords
androsten
17beta
hydroxy
ones
producing new
Prior art date
Application number
AT348378A
Other languages
English (en)
Other versions
AT360676B (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772722705 external-priority patent/DE2722705A1/de
Priority claimed from DE19772722706 external-priority patent/DE2722706A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of ATA348378A publication Critical patent/ATA348378A/de
Application granted granted Critical
Publication of AT360676B publication Critical patent/AT360676B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0073 membered carbocyclic rings in position 6-7
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001Lactones
    • C07J21/003Lactones at position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT348378A 1977-05-16 1978-05-12 Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen AT360676B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772722705 DE2722705A1 (de) 1977-05-16 1977-05-16 Androsta-4.15-dien-3-one und verfahren zu ihrer herstellung
DE19772722706 DE2722706A1 (de) 1977-05-16 1977-05-16 15.16-methylen-androsta-4.15-dien- 3-one und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ATA348378A true ATA348378A (de) 1980-06-15
AT360676B AT360676B (de) 1981-01-26

Family

ID=25772043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT348378A AT360676B (de) 1977-05-16 1978-05-12 Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen

Country Status (21)

Country Link
US (1) US4180570A (de)
JP (1) JPS53141258A (de)
AT (1) AT360676B (de)
AU (1) AU515595B2 (de)
CA (1) CA1105004A (de)
CH (1) CH639105A5 (de)
CS (1) CS200235B2 (de)
DD (1) DD135497A5 (de)
DK (1) DK147406C (de)
ES (1) ES469510A1 (de)
FR (1) FR2391224A1 (de)
GB (1) GB1602986A (de)
GR (1) GR71590B (de)
HU (1) HU179345B (de)
IE (1) IE46896B1 (de)
IL (1) IL54718A (de)
IT (1) IT1094627B (de)
LU (1) LU79652A1 (de)
NL (1) NL7805114A (de)
SE (2) SE433356B (de)
SU (1) SU786905A3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2922500A1 (de) * 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3130644A1 (de) * 1981-07-29 1983-02-17 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
JPS5921698A (ja) * 1982-07-22 1984-02-03 シエ−リング・アクチエンゲゼルシヤフト 17α−プレグネ−4−エン−3−オキソ−21−カルボン酸エステル、その製法およびこれを含有する抗アンドロゲン作用を有する医薬
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
JPS6248694A (ja) * 1985-08-28 1987-03-03 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH609357A5 (de) * 1973-05-25 1979-02-28 Schering Ag
DE2439082A1 (de) * 1974-08-12 1976-02-26 Schering Ag 17 alpha-hydroxy-1,3,5(10),15-oestratetraene und verfahren zu ihrer herstellung
IE44711B1 (en) * 1976-03-05 1982-03-10 Schering Ag 17 -hydroxypropyl-4-3-keto-steroids and esters thereof, and process for their manufacture

Also Published As

Publication number Publication date
IL54718A (en) 1982-08-31
DK147406B (da) 1984-07-23
US4180570A (en) 1979-12-25
CA1105004A (en) 1981-07-14
AU3615578A (en) 1979-11-22
SE7805413L (sv) 1978-11-17
GR71590B (de) 1983-06-17
AT360676B (de) 1981-01-26
DK213878A (da) 1978-11-17
IL54718A0 (en) 1978-07-31
AU515595B2 (en) 1981-04-09
FR2391224A1 (fr) 1978-12-15
IT1094627B (it) 1985-08-02
GB1602986A (en) 1981-11-18
CH639105A5 (de) 1983-10-31
CS200235B2 (en) 1980-08-29
FR2391224B1 (de) 1980-06-13
DK147406C (da) 1985-02-11
LU79652A1 (de) 1978-11-06
ES469510A1 (es) 1978-12-01
IE780977L (en) 1978-11-16
SE8100829L (sv) 1981-02-05
IE46896B1 (en) 1983-10-19
HU179345B (en) 1982-10-28
NL7805114A (nl) 1978-11-20
SE433356B (sv) 1984-05-21
DD135497A5 (de) 1979-05-09
SU786905A3 (ru) 1980-12-07
JPS53141258A (en) 1978-12-08
IT7823392A0 (it) 1978-05-15

Similar Documents

Publication Publication Date Title
AT372093B (de) Verfahren zur herstellung von neuen corticoid-17- alkylcarbonaten
AT367425B (de) Verfahren zur herstellung von neuen cephemderivaten
AT367426B (de) Verfahren zur herstellung von neuen cephemderivaten
AT360153B (de) Verfahren zur herstellung von neuen ver- bindungen
AT362065B (de) Verfahren zur herstellung von neuen pleuromutilinglycosidderivaten
LU79212A1 (de) Verfahren zur herstellung von neuen 4-acylamino-phenylaethanolaminen
AT363182B (de) Verfahren zur herstellung von neuen cephemderivaten
AT368753B (de) Verfahren zur herstellung von neuen azacycloalkanen
AT371455B (de) Verfahren zur herstellung von neuen prostanderivaten
AT361455B (de) Verfahren zur herstellung von neuen substituierten 3-phenyl-cycloalkan- oder - -cycloalken-1-olen
AT368137B (de) Verfahren zur herstellung von neuen 4-amino-5alkylthiopyrimidinen
AT366368B (de) Verfahren zur herstellung von neuen chinolylguanidinen
AT357673B (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
AT361622B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosid-anitbiotika
AT365591B (de) Verfahren zur herstellung von neuen indolderivaten
AT358169B (de) Verfahren zur herstellung von neuen ver- bindungen
AT357677B (de) Verfahren zur herstellung von neuen azacyclyl- -verbindungen
AT362368B (de) Verfahren zur herstellung von neuen oxazolidin- 2-on-derivaten
AT372690B (de) Verfahren zur herstellung von neuen polyhydantoinen
AT360676B (de) Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen
ATA750578A (de) Verfahren zur herstellung von neuen pyridothiazo- linen
AT365203B (de) Verfahren zur herstellung von neuen 9-fluorprednisolon-derivaten
AT372954B (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
AT359517B (de) Verfahren zur herstellung von neuen alfa- -halogenaethylcarbamidsaeurehalogeniden
AT365610B (de) Verfahren zur herstellung von neuen 19-nor-10cyano-peruvosid-derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee